Indication
Alzheimer's disease
Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults. Read more about Alzheimer's disease
3 drugs 2 manufacturers
Drugs that treat it
Common Alzheimer's disease therapies.
KISUNLA (donanemab-azbt)
LEQEMBI IQLIK (lecanemab-irmb)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAlzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults.
Pathophysiologically, it is defined by the extracellular accumulation of amyloid-beta plaques, the intracellular aggregation of hyperphosphorylated tau proteins into neurofibrillary tangles, widespread synaptic dysfunction, and neuronal loss predominantly in the hippocampus and cerebral cortex.
Clinically, the disease characteristically presents with insidious short-term memory impairment and gradually advances to severe deficits in executive function, language, visuospatial abilities, and behavioral regulation, ultimately compromising the individual's ability to perform routine activities of daily living.
- medlineplus.gov
Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults Clinically, the disease characteristically presents with insidious short-term memory impairment and gradually advances to severe deficits in executive function, language, visuospatial abilities, and behavioral regulation, ultimately compromising the individual's ability to perform routine activities of daily living
- nih.gov
Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults Pathophysiologically, it is defined by the extracellular accumulation of amyloid-beta plaques, the intracellular aggregation of hyperphosphorylated tau proteins into neurofibrillary tangles, widespread synaptic dysfunction, and neuronal loss predominantly in the hippocampus and cerebral cortex
- nih.gov
Alzheimer's disease is an irreversible, progressive neurodegenerative disorder of the central nervous system and the most common cause of dementia in older adults Clinically, the disease characteristically presents with insidious short-term memory impairment and gradually advances to severe deficits in executive function, language, visuospatial abilities, and behavioral regulation, ultimately compromising the individual's ability to perform routine activities of daily living
- nih.gov
Pathophysiologically, it is defined by the extracellular accumulation of amyloid-beta plaques, the intracellular aggregation of hyperphosphorylated tau proteins into neurofibrillary tangles, widespread synaptic dysfunction, and neuronal loss predominantly in the hippocampus and cerebral cortex
- nih.gov
Pathophysiologically, it is defined by the extracellular accumulation of amyloid-beta plaques, the intracellular aggregation of hyperphosphorylated tau proteins into neurofibrillary tangles, widespread synaptic dysfunction, and neuronal loss predominantly in the hippocampus and cerebral cortex Clinically, the disease characteristically presents with insidious short-term memory impairment and gradually advances to severe deficits in executive function, language, visuospatial abilities, and behavi...
Personalize your experience
Follow Alzheimer's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.